** Shares of Opyl OPL.AX rise as much as 7.4% to A$0.029,
their highest level since June 14
** The medical research technology co signs a memorandum of
understanding (MOU) with Xco consortium for expansion in EMEA
and North America markets
** Co and Xco consortium to form a joint venture (JV) for
exclusive sale of co's products in Europe, Middle East, Africa
and North America
** Says JV entity will seek to undertake a capital raise to
secure between $3 mln and $5 mln within nine months of
establishment
** About 963,000 shares change hands, 2.9 times the 30-day
average volume of shares
** Stock has fallen 3.6% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))